Global Drug Device Combination Products Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, And Growth Forecast To 2027

Introduction:

A combination product is a product composed of any combination such as drug and a device, a biological product and a device, a drug and a biological product, and a drug, device, and a biological product. Combination products are therapeutic and diagnostic products that combine drugs, devices, and or biological products.

Market Dynamics:

Key factors expected to drive growth of the global drug device combination products market is increasing incidence of chronic diseases such as diabetes, cancer, and respiratory problems. In addition, increasing healthcare expenditure, government initiatives, CSR activities conducted by major players, growing concerns related to obesity and diabetes, rising elderly population are among some other factors expected to drive growth of the global drug device combination products market. However, string regulatory rule may hamper the growth of the global drug device combination products market to a certain extent. In addition, several product recall is expected to hamper the growth of the target market.

Trends and Opportunity:

Government and NGO are taking initiatives to promote the awareness regarding drug delivery implants in different developing regions across the globe. Major manufacturers are focus on developing portable medical devices for taking medication such as nebulizers, implant, and inhalers, due to shifting patient’s preferences for minimally invasive surgeries and portable devices over convention devices. On the contrary, rise in healthcare infrastructure and high market potential in emerging countries are anticipated to serve as lucrative opportunities for target market expansion in the forecoming years.

Regional Analysis:

The market in North America is expected to dominate the global drug device combination products market, owing to increasing incidences chronic diseases such as respiratory and cardiovascular diseases in countries in the region. In contrast, the market in Asia Pacific is expected to be an emerging market for the global drug device combination products market, and is expected to register highest CAGR in during the forecasted period, owing to improvement in patient awareness about combination devices and increasing healthcare expenditure in the region. Moreover, the markets in Europe, Latin America and Middle East & Africa are expected to register moderate growth revenue over the forecast period.

GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET SEGMENTATION:

Segmentation by product:

• Drug-eluting stent
  • Coronary drug-eluting stent
  • Peripheral drug-eluting stent

• Infusion pump
  • Implantable infusion pump
  • Insulin infusion pump
  • Patient-controlled analgesia pump
  • Ambulatory infusion pump

• Photodynamic therapy
• Antimicrobial wound dressing
• Prefilled syringe
  • Single-chamber prefilled syringe
  • Dual-chamber prefilled syringe
  • Customized prefilled syringe

• Drug-eluting balloon
  • Coronary drug-eluting balloon
  • Peripheral drug-eluting balloon

• Nebulizer
• Inhaler
  • Drug powder inhaler (DPI)
  • Metered dose inhaler (MDI)
  • Soft mist inhaler (SMI)

• Transdermal delivery system
  • Passive delivery system
  • Active delivery system

Segmentation by wound type:

• Cardiovascular disease
• Diabetes
• Respiratory problem
• Cancer treatment
• Antimicrobial application
• Other applications (include neurological, skin treatments, etc.)

Segmentation by end user:

• Hospital & clinic
• Ambulatory surgery center (ASC)
• Home care setting

Segmentation by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa